Home > > > > > Report Detail

Gastroesophageal Reflux Disease (GERD) - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Gastroesophageal Reflux Disease (GERD) - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Gastroesophageal Reflux Disease (GERD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Gastroesophageal Reflux Disease (GERD) Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Gastroesophageal Reflux Disease (GERD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Gastroesophageal Reflux Disease (GERD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Gastroesophageal Reflux Disease (GERD) scenario.

Gastroesophageal Reflux Disease (GERD) Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Gastroesophageal Reflux Disease (GERD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Gastroesophageal Reflux Disease (GERD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Gastroesophageal Reflux Disease (GERD) Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Gastroesophageal Reflux Disease (GERD)

Key assessments

- Patient Segmentation in Gastroesophageal Reflux Disease (GERD)

- Gastroesophageal Reflux Disease (GERD) Risk & Burden

- Factors driving growth in a specific Gastroesophageal Reflux Disease (GERD) patient population

Gastroesophageal Reflux Disease (GERD) - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Gastroesophageal Reflux Disease (GERD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Gastroesophageal Reflux Disease (GERD) in 2016
2.2. Patient Share Distribution of Gastroesophageal Reflux Disease (GERD) in 2028
3. Disease Background and Overview: Gastroesophageal Reflux Disease (GERD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Gastroesophageal Reflux Disease (GERD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Gastroesophageal Reflux Disease (GERD) in 7MM - By Countries
5. Epidemiology of Gastroesophageal Reflux Disease (GERD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.1.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.1.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.1.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.4.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.4.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.4.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.5.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.5.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.5.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.6.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.6.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.6.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.7.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.7.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.7.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.8.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.8.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.8.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD)
5.9.3. Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) *
5.9.4. Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) *
5.9.5. Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD)
6. Unmet Needs of the Gastroesophageal Reflux Disease (GERD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Gastroesophageal Reflux Disease (GERD) in Japan (2016-2028)

  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs